Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.

Saved in:
Bibliographic Details
Title: Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
Authors: Sulea T; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada., Stuible M; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Moreno M; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Pelletier A; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Rossotti MA; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Cepero-Donates Y; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Slinn J; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Salois P; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Tran A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Hewitt M; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Yogi A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Rohani N; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Cass B; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Lenferink AEG; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Tanha J; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.; Center for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Ontario, Canada., Ling B; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Lessard E; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Delafosse L; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada., Sandhu JK; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada., Stanimirovic D; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2026 May 06; Vol. 70 (5), pp. e0002426. Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00024-26